NASDAQ:RAIN

Rain Therapeutics Stock Forecast

etoro logo Buy RAIN
*Your capital is at risk
$1.18
+0 (+0%)
At Close: Aug 10, 2026

Should you buy RAIN stock?

Last updated:

Based on market data through , StockInvest.us rates Rain Therapeutics Inc. (RAIN) as a Strong Sell Candidate with a technical score of -7.18 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 43.00%
  • 3-month trend forecast Down 28.25%
  • Strong Sell Candidate -7.18
AI Analysis AI Analysis of RAIN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RAIN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Rain Therapeutics Inc. stock price ended at $1.18 on Monday, after losing 0%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 30, 2026 Loss -43.00%

No changes to the price of Rain Therapeutics Inc. stock on the last trading day (Monday, 10th Aug 2026). During the last trading day the stock fluctuated 4.12% from a day low at $1.16 to a day high of $1.21. The price has risen in 6 of the last 10 days but is still down by -9.58% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.25% during the next 3 months and, with a 90% probability hold a price between $0.523 and $1.33 at the end of this 3-month period.

RAIN Signals & Forecast

There are few to no technical positive signals at the moment. The Rain Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.30 and $1.68. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -52.03%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Support, Risk & Stop-loss for Rain Therapeutics Inc. stock

Rain Therapeutics Inc. finds support from accumulated volume at $1.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0479 between high and low, or 4.12%. For the last week the stock has had daily average volatility of 14.67%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RAIN) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Rain Therapeutics Inc. to open at $1.18, and during the day (based on 14 day Average True Range), to move between $1.08 and $1.28, which gives a possible trading interval of +/-$0.197 (+/-18.18%) up or down from last closing price. If Rain Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 18.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.16 (1.69%) than the resistance at $1.26 (6.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Rain Therapeutics Inc. stock A Buy?

Rain Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -7.183 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $1.18 ( 0.342%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RAIN Performance

Trading levels for RAIN

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.23 4.40%
R2 1.21 2.85%
R1 1.20 1.89%
Price 1.18
S1 1.17 -1.21%
S2 1.15 -2.17%
S3 1.14 -3.72%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.46 23.73%
R2 1.27 7.63%
R1 1.26 6.78%
Price 1.18
S1 1.16 -1.69%
S2 0 -
S3 0 -

FAQ

What is the symbol for Rain Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Rain Therapeutics Inc. is RAIN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rain Therapeutics Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Rain Therapeutics Inc. (RAIN) as a Strong Sell Candidate with a technical score of -7.18 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Jun 30, 2026, the price has fallen 43.00%. The current 3-month trend forecast projects a fall of 28.25%.

How to buy Rain Therapeutics Inc. Stock?
Rain Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rain Therapeutics Inc. Stock.

What's the current price of Rain Therapeutics Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Rain Therapeutics Inc. (RAIN) share was $1.18.

What is the 52-week high and low for Rain Therapeutics Inc. Stock?
The 52-week high for Rain Therapeutics Inc. Stock is $8.50 and the 52-week low is $1.14.

What is the market capitalization of Rain Therapeutics Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Rain Therapeutics Inc. is 9.65M.
Click to get the best stock tips daily for free!
ABOUT RAIN THERAPEUTICS INC.
Rain Therapeutics
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinica...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE